A Detailed Clinical Case of Localized Prostate Tumors Treated with Nanoparticle-Assisted Sub-Ablative Laser Ablation
Open Access
- 28 July 2024
- journal article
- case report
- Published by MDPI AG in Nanomaterials
- Vol. 14 (15) , 1261
Abstract
AuroLase® Therapy—a nanoparticle-enabled focal therapy—has the potential to safely and effectively treat localized prostate cancer (PCa), preserving baseline functionality. This article presents a detailed case of localized PCa treated with AuroLase, providing insight on expectations from the diagnosis of PCa to one year post-treatment. AuroLase Therapy is a two-day treatment consisting of a systemic infusion of gold nanoshells (~150-nm hydrodynamic diameter) on Day 1, and sub-ablative laser treatment on Day 2. Multiparametric MRI (mpMRI) was used for tumor visualization, treatment planning, and therapy response assessment. The PCa was targeted with a MR/Ultrasound-fusion (MR/US) transperineal approach. Successful treatment was confirmed at 6 and 12 months post-treatment by the absence of disease in MR/US targeted biopsies. On the mpMRI, confined void space was evident, an indication of necrotic tissues encompassing the treated lesion, which was completely resolved at 12 months, forming a band-like scar with no evidence of recurrent tumor. The patient’s urinary and sexual functions were unchanged. During the one-year follow-up, changes on the DCE sequence and in the Ktrans and ADC values assist in qualitatively and quantitatively evaluating tissue changes. The results highlight the potential of gold-nanoparticle-enabled sub-ablative laser treatment to target and control localized PCa, maintain quality of life, and preserve baseline functionality.Keywords
Funding Information
- Nanospectra Biosciences, Inc. (C-1220)
- Welch Foundatio (C-1220)
This publication has 69 references indexed in Scilit:
- E‐cadherin is downregulated in benign prostatic hyperplasia and required for tight junction formation and permeability barrier in the prostatic epithelial cell monolayerThe Prostate, 2019
- The systematic evaluation of size-dependent toxicity and multi-time biodistribution of gold nanoparticlesColloids and Surfaces B: Biointerfaces, 2018
- Transperineal Magnetic Resonance Imaging-targeted Biopsy versus Transperineal Template Prostate Mapping Biopsy in the Detection of Localised Radio-recurrent Prostate CancerClinical Oncology, 2016
- MRI-guided focal laser ablation for prostate cancer followed by radical prostatectomy: correlation of treatment effects with imagingWorld Journal of Urology, 2016
- The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivoAdvanced Drug Delivery Reviews, 2013
- Selective nanoparticle‐directed ablation of the canine prostateLasers in Surgery and Medicine, 2011
- Nanoshell-mediated photothermal therapy improves survival in a murine glioma modelJournal of Neuro-Oncology, 2010
- Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacyAdvanced Drug Delivery Reviews, 2009
- Monitoring prostate thermal therapy with diffusion‐weighted MRIMagnetic Resonance in Medicine, 2008
- Quality of life and symptoms in a randomized trial of radiotherapy versus deferred treatment of localized prostate carcinomaCancer, 2001